State Street Corp Altimmune, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Altimmune, Inc. stock. As of the latest transaction made, State Street Corp holds 3,470,017 shares of ALT stock, worth $22.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,470,017
Previous 3,413,827
1.65%
Holding current value
$22.1 Million
Previous $21 Million
19.36%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ALT
# of Institutions
208Shares Held
39.5MCall Options Held
1.94MPut Options Held
1.38M-
Black Rock Inc. New York, NY5.32MShares$33.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.25MShares$33.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$28.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$17.5 Million1.49% of portfolio
-
Geode Capital Management, LLC Boston, MA1.66MShares$10.6 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $312M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...